Abstract
Insulin-like growth factor-1 (IGF-1) plays a central role in cellular growth, differentiation, survival, and cell cycle progression. It is expressed early during development and its effects are mediated through binding to a tyrosine kinase receptor, the insulin-like growth factor-1 receptor (IGF-1R). In the circulation, the IGFs bind to IGF-binding proteins (IGFBPs), which determine their bioavailability and regulate the interaction between the IGFs and IGF-1R. Studies in animal models and in humans have established critical roles for IGFs in skeletal growth and development. In this review we present new and old findings from mouse models of the IGF system and discuss their clinical relevance to normal and pathological skeletal physiology.
Original language | English (US) |
---|---|
Pages (from-to) | 2543-2552 |
Number of pages | 10 |
Journal | Journal of Bone and Mineral Research |
Volume | 25 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2010 |
Keywords
- Bone Accrual
- Cortical-Bone
- Growth Hormone
- Insulin-Like Growth Factor
- Skeletal Growth
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Orthopedics and Sports Medicine